Palisade Bio to Present at the Virtual Investor Pitch Conference
Palisade Bio (Nasdaq: PALI), a biopharmaceutical company, is set to present at the Virtual Investor Pitch Conference on June 17, 2024, at 12:00 PM ET. J.D. Finley, the CEO, will deliver an 'elevator pitch' and outline the company's forthcoming milestones. The event offers investors and interested parties the chance to submit live questions. A live video webcast will be available on the company's website, with a replay accessible for 90 days post-event.
- Palisade Bio is actively engaging with investors through the Virtual Investor Pitch Conference.
- The live webcast provides a platform for direct investor interaction and queries.
- The presentation will outline upcoming milestones, potentially signaling future growth and developments.
- The announcement lacks specific details on financial performance or recent clinical trial results, which are important for investors.
- The impact of the event on stock price is uncertain and relies heavily on the content and reception of the presentation.
Live video webcast on Monday, June 17th at 12:00 PM ET
Carlsbad, CA, June 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the Virtual Investor Pitch Conference on June 17, 2024 at 12:00 PM ET.
As part of the event, J.D. Finley, Chief Executive Officer of Palisade Bio, will provide an “elevator pitch” and outline the Company’s upcoming milestones. Additionally, investors and interested parties will have the opportunity to submit questions live during the event. Participating companies will answer as many questions as possible in the time allowed.
A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
About Palisade Bio
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
PALI@jtcir.com
FAQ
When is Palisade Bio's presentation at the Virtual Investor Pitch Conference?
What will Palisade Bio discuss at the Virtual Investor Pitch Conference?
How can I watch Palisade Bio's presentation at the Virtual Investor Pitch Conference?
Will there be an opportunity to ask questions during Palisade Bio's presentation?
